US 9506926
Molecular predictors of therapeutic response to specific anti-cancer agents
granted A61KA61K31/165A61K31/167
Quick answer
US patent 9506926 (Molecular predictors of therapeutic response to specific anti-cancer agents) held by The Regents of the University of California expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/165, A61K31/167, A61K31/437, A61K31/513